Simplex Trading, LLC Aerie Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$6.37 - $15.23 $26,244 - $62,747	4,120 New	4,120 $62,000
Q2 2022 Aug 03, 2022	SELL	$4.95 - $9.16 $7,484 - $13,849	-1,512 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$5.64 - $9.8 $5,724 - $9,947	-1,015 Reduced 40.17%	1,512 $13,000
Q4 2021 Feb 23, 2022	BUY	$7.02 - $13.33 $12,432 - $23,607	1,771 Added 234.26%	2,527 $17,000
Q3 2021 Oct 28, 2021	BUY	$11.32 - $16.63 $1,132 - $1,663	100 Added 15.24%	756 $12,000
Q2 2021 Aug 12, 2021	SELL	$15.16 - $18.97 $3,426 - $4,287	-226 Reduced 25.62%	656 $10,000
Q1 2021 Apr 26, 2021	BUY	$13.12 - $20.9 $11,571 - $18,433	882 New	882 $15,000
Q4 2020 Feb 02, 2021	SELL	$9.12 - $14.49 $71,719 - $113,949	-7,864 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$10.46 - $14.46 $73,805 - $102,029	7,056 Added 873.27%	7,864 $92,000
Q2 2020 Jul 13, 2020	SELL	$12.0 - $16.13 $44,496 - $59,810	-3,708 Reduced 82.11%	808 $11,000
Q1 2020 Apr 29, 2020	BUY	$11.84 - $25.52 $53,469 - $115,248	4,516 New	4,516 $60,000
Q4 2019 Feb 05, 2020	SELL	$17.72 - $25.1 $212,799 - $301,425	-12,009 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$18.41 - $28.0 $268,859 - $408,912	-14,604 Reduced 54.88%	12,009 $230,000
Q2 2019 Jul 26, 2019	BUY	$28.97 - $48.21 $64,255 - $106,929	2,218 Added 9.09%	26,613 $786,000
Q1 2019 Apr 18, 2019	BUY	$36.32 - $49.25 $478,915 - $649,410	13,186 Added 117.64%	24,395 $0
Q4 2018 Jan 16, 2019	SELL	$33.0 - $60.04 $341,352 - $621,053	-10,344 Reduced 47.99%	11,209 $404,000
Q3 2018 Oct 23, 2018	BUY	$56.15 - $73.9 $778,070 - $1.02 Million	13,857 Added 180.05%	21,553 $1.33 Million
Q2 2018 Jul 30, 2018	BUY	$47.85 - $70.45 $283,463 - $417,345	5,924 Added 334.31%	7,696 $519,000
Q1 2018 Apr 26, 2018	BUY	$51.15 - $61.0 $90,637 - $108,092	1,772 New	1,772 $96,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account